Additional evidence for the role of VEGF-C/VEGF-D/VEGFR-3 in the pathogenesis of lymphatic dilation and lymphedema stems from experimental studies in transgenic mice with skin-specific overexpression of soluble VEGFR-3 (sVEGFR-3) using a keratin 14 transgenic promoter. Here, VEGFD is linked to lymphedema.